S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61

NantHealth Stock Forecast, Price & News

0.00 (0.00%)
(As of 12/8/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
65,871 shs
Average Volume
270,199 shs
Market Capitalization
$126.99 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive NH News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

NantHealth logo

About NantHealth

NantHealth, Inc. is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. Its solutions include empower treatment decisions; improve patient outcomes; validate treatment options; enable high-quality care; lower costs; ensure appropriate reimbursement; and streamline implementation and deployment. The company was founded by Patrick Soon-Shiong in July 2010 and is headquartered in Culver City, CA.


Form 10-Q NantHealth, Inc. For: Sep 30 - StreetInsider.com
November 6, 2021 |  streetinsider.com
NantHealth Reports 2021 Third Quarter Financial Results
November 4, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Data processing & preparation
Year Founded

Sales & Book Value

Annual Sales
$73.17 million
Book Value
($1.27) per share


Net Income
$-56.33 million
Pretax Margin




Free Float
Market Cap
$126.99 million

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)


Overall MarketRank

1.48 out of 5 stars

Medical Sector

1087th out of 1,394 stocks

Data Processing & Preparation Industry

71st out of 102 stocks

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -

NantHealth (NASDAQ:NH) Frequently Asked Questions

How has NantHealth's stock been impacted by COVID-19 (Coronavirus)?

NantHealth's stock was trading at $1.81 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NH stock has decreased by 39.2% and is now trading at $1.10.
View which stocks have been most impacted by COVID-19

When is NantHealth's next earnings date?

NantHealth is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for NantHealth

How were NantHealth's earnings last quarter?

NantHealth, Inc. (NASDAQ:NH) posted its quarterly earnings results on Thursday, November, 4th. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.08) by $0.02. During the same quarter in the prior year, the business earned ($0.08) earnings per share.
View NantHealth's earnings history

Who are NantHealth's key executives?

NantHealth's management team includes the following people:

What is Patrick Soon-Shiong's approval rating as NantHealth's CEO?

82 employees have rated NantHealth CEO Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among NantHealth's employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of NantHealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK), AbbVie (ABBV), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH) and Netflix (NFLX).

When did NantHealth IPO?

(NH) raised $91 million in an initial public offering (IPO) on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

Who are NantHealth's major shareholders?

NantHealth's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (1.18%), Geode Capital Management LLC (0.53%), B. Riley Wealth Management Inc. (0.20%), Millennium Management LLC (0.10%) and Morgan Stanley (0.07%). Company insiders that own NantHealth stock include Patrick Soon-Shiong and Ronald Allen Louks.
View institutional ownership trends for NantHealth

Which major investors are selling NantHealth stock?

NH stock was sold by a variety of institutional investors in the last quarter, including Geode Capital Management LLC, and Morgan Stanley.
View insider buying and selling activity for NantHealth
or view top insider-selling stocks.

Which major investors are buying NantHealth stock?

NH stock was purchased by a variety of institutional investors in the last quarter, including B. Riley Wealth Management Inc., Millennium Management LLC, and BlackRock Inc..
View insider buying and selling activity for NantHealth
or or view top insider-buying stocks.

How do I buy shares of NantHealth?

Shares of NH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NantHealth's stock price today?

One share of NH stock can currently be purchased for approximately $1.10.

How much money does NantHealth make?

NantHealth has a market capitalization of $126.99 million and generates $73.17 million in revenue each year. The company earns $-56.33 million in net income (profit) each year or ($0.54) on an earnings per share basis.

How many employees does NantHealth have?

NantHealth employs 354 workers across the globe.

What is NantHealth's official website?

The official website for NantHealth is www.nanthealth.com.

Where are NantHealth's headquarters?

NantHealth is headquartered at 9920 JEFFERSON BLVD, CULVER CITY CA, 90232.

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company can be reached via phone at (310) 883-1300 or via email at [email protected].

This page was last updated on 12/9/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.